{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T15:34:50Z","timestamp":1761924890388,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1093\/annonc\/mdf206","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T18:40:11Z","timestamp":1033411211000},"page":"1290-1299","source":"Crossref","is-referenced-by-count":5,"title":["Primary cutaneous non-Hodgkin\u2019s lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement"],"prefix":"10.1016","volume":"13","author":[{"given":"C.","family":"Visco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.J.","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Romaguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.","family":"Sarris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf206_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/annonc\/11.suppl_3.219","article-title":"Extranodal lymphomas","volume":"11","author":"Zucca","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0015","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0360-3016(86)90009-X","article-title":"Cutaneous malignant lymphoma","volume":"12","author":"Esche","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdf206_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/annonc\/11.suppl_1.S11","article-title":"EORTC classification for primary cutaneous lymphomas: a comparison with the REAL classification and the proposed WHO classification","volume":"11","author":"Willemze","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0025","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0733-8635(18)30866-0","article-title":"Cutaneous B-cell lymphoma","volume":"3","author":"Burg","year":"1985","journal-title":"Dermatol Clin"},{"key":"10.1093\/annonc\/mdf206_bb0030","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1200\/JCO.2000.18.10.2152","article-title":"Primary cutaneous B-cell lymphoma: review and current concepts","volume":"18","author":"Pandolfino","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0035","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/8.suppl_2.S29","article-title":"Primary B-cell lymphomas of the skin","volume":"8","author":"Kerl","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0045","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","article-title":"Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases","volume":"67","author":"Santucci","year":"1991","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf206_bb0050","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.1996.14.2.549","article-title":"Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy","volume":"14","author":"Rijlaarsdam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0060","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.1991.9.11.1994","article-title":"Cutaneous lymphomas other than mycosis fungoides: follow-up study of 52 patients","volume":"9","author":"Joly","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0065","first-page":"713","article-title":"Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdf206_bb0070","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients","volume":"17","author":"Bekkenk","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.leu.2400911","article-title":"Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas","volume":"12","author":"Brice","year":"1998","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdf206_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases","volume":"52","author":"Kirova","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0360-3016(93)90251-P","article-title":"Radiotherapy of cutaneous B-cell lymphomas","volume":"27","author":"Piccinno","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdf206_bb0090","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0190-9622(88)70169-3","article-title":"Reticulohistiocytoma of the dorsum","volume":"19","author":"Berti","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1093\/annonc\/mdf206_bb0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2001.19.2.398","article-title":"Primary cutaneous non-Hodgkin\u2019s lymphoma of Ann Arbor Stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy","volume":"19","author":"Sarris","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0100","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-122-3-199502010-00009","article-title":"Lymphomatoid papulosis: a T-cell dyscrasia with a propensity to transform into malignant lymphoma","volume":"122","author":"Cabanillas","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdf206_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/oxfordjournals.annonc.a058324","article-title":"A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the \u2018tumor score","volume":"3","author":"Rodriguez","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0115","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf206_bb0120","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas: summary and description of a working formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf206_bb0125","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0130","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I","article-title":"Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma","volume":"38","author":"McKelvey","year":"1976","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf206_bb0135","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.1986.4.10.1455","article-title":"A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma","volume":"4","author":"Lee","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0140","first-page":"273a","article-title":"Successful outcome of patients with good risk large cell lymphoma (LCL) with a shortened schedule of treatment (RX)","volume":"10","author":"Swan","year":"1991","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0145","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.1995.13.10.2530","article-title":"Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin\u2019s lymphoma using CHOP versus CNOP chemotherapy","volume":"13","author":"Sonneveld","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez","year":"1988","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0155","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/1097-0142(19940501)73:9<2408::AID-CNCR2820730926>3.0.CO;2-M","article-title":"Intermediate-grade lymphomas treated with cyclophosphamide\u2013doxorubicin\u2013vincristine\u2013prednisone\u2013bleomycin alternated with cyclophosphamide\u2013methotrexate\u2013etoposide\u2013dexamethasone. Application of prognostic models to data analysis","volume":"73","author":"Velasquez","year":"1994","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf206_bb0160","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1008214629544","article-title":"Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma","volume":"9","author":"Cabanillas","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdf206_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with Discussion)","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1093\/annonc\/mdf206_bb0180","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7","article-title":"Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients","volume":"71","author":"Beljaards","year":"1993","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf206_bb0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d\u2019Etude des Lymphomes Agressives)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdf206_bb0190","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00000478-198607000-00002","article-title":"Cutaneous follicular lymphoma","volume":"10","author":"Garcia","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/annonc\/mdf206_bb0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2230.1989.tb00875.x","article-title":"Primary cutaneous follicular centre-cell lymphoma\u2014a lymphoproliferative disease with favourable prognosis","volume":"14","author":"Pimpinelli","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1093\/annonc\/mdf206_bb0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1093\/annonc\/mdf206_bb0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1523-1747.ep12531102","article-title":"Characterization of T-cell subpopulations in skin and peripheral blood of patients with cutaneous T-cell lymphomas and benign inflammatory dermatoses","volume":"80","author":"Willemze","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1093\/annonc\/mdf206_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood.V60.2.463.463","article-title":"Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates","volume":"60","author":"Haynes","year":"1982","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0220","first-page":"859","article-title":"Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associated antigen expression on T cells correlates with extent of disease","volume":"7","author":"Borowitz","year":"1993","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdf206_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2559.1992.tb00343.x","article-title":"Differential expression of the HECA-452 antigen (cutaneous lymphocyte associated antigen, CLA) in cutaneous and non-cutaneous T-cell lymphomas","volume":"21","author":"Noorduyn","year":"1992","journal-title":"Histopathology"},{"key":"10.1093\/annonc\/mdf206_bb0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s004030050199","article-title":"T-cell population of primary and secondary cutaneous B-cell lymphomas does not express the cutaneous lymphocyte-associated antigen (CLA)","volume":"289","author":"Marti","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"10.1093\/annonc\/mdf206_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2567.1998.00551.x","article-title":"Characterization of E-selectin-binding epitopes expressed by skin-homing T cells","volume":"94","author":"Priest","year":"1998","journal-title":"Immunology"},{"key":"10.1093\/annonc\/mdf206_bb0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdf206_bb0245","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood.V86.2.651.bloodjournal862651","article-title":"Cytokine loops involving interferon-\u03b3 and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?","volume":"86","author":"Sarris","year":"1995","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/10428199809068568","article-title":"Tumor necrosis factor-\u03b1 and interferon-\u03b3, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10","volume":"29","author":"Daliani","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdf206_bb0255","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V87.4.1423.bloodjournal8741423","article-title":"Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice","volume":"87","author":"Taub","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdf206_bb0260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides","volume":"115","author":"Lu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/annonc\/mdf206_bb0265","first-page":"757","article-title":"Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors","volume":"10","author":"Sarris","year":"1996","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdf206_bb0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.1711720110","article-title":"Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma","volume":"172","author":"Beljaards","year":"1994","journal-title":"J Pathol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419638354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419638354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/8\/1290\/333812\/mdf206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T04:52:12Z","timestamp":1733806332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419638354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0923753419638354"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf206","relation":{},"ISSN":["0923-7534"],"issn-type":[{"type":"print","value":"0923-7534"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}